prednisolone 21-3-sulfobenzoate has been researched along with Acute Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Darlow, SJ; Mandal, A; Mayberry, JF; Pick, B; Robinson, RJ; Thomas, T | 1 |
| Axon, AT; Dickinson, RJ; Dixon, MF; Hamilton, I; Pinder, IF; Ruddell, WS | 1 |
1 trial(s) available for prednisolone 21-3-sulfobenzoate and Acute Disease
| Article | Year |
|---|---|
A comparison of prednisolone enemas with low-dose oral prednisolone in the treatment of acute distal ulcerative colitis.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Colitis, Ulcerative; Enema; Female; Humans; Male; Middle Aged; Prednisolone; Prospective Studies | 1984 |
1 other study(ies) available for prednisolone 21-3-sulfobenzoate and Acute Disease
| Article | Year |
|---|---|
The short-term effects of Eudragit-L-coated prednisolone metasulphobenzoate (Predocol) on bone formation and bone mineral density in acute ulcerative colitis.
Topics: Acute Disease; Adult; Aged; Anti-Inflammatory Agents; Bone Density; Colitis, Ulcerative; Delayed-Action Preparations; Drug Compounding; Female; Humans; Longitudinal Studies; Male; Middle Aged; Osteocalcin; Osteogenesis; Polymethacrylic Acids; Prednisolone; Treatment Outcome | 2004 |